NovoCure (NASDAQ:NVCR) Rating Lowered to “Sell” at StockNews.com
StockNews.com cut shares of NovoCure (NASDAQ:NVCR – Free Report) from a hold rating to a sell rating in a research report report published on Saturday. A number of other research firms also recently ...
Research Analysts Issue Forecasts for GameStop Q1 Earnings
Equities research analysts at Wedbush upped their Q1 2026 earnings per share (EPS) estimates for shares of GameStop in a report released on Wednesday, March 26th. Wedbush analyst M. Pachter now ...
Protesters rebelling against Elon Musk's purge of US government swarm Tesla showrooms
Crowds protesting billionaire Elon Musk's purge of the U.S. government under President Donald Trump began amassing outside ...
Wedbush Keeps Their Buy Rating on Texas Roadhouse (TXRH)
In a report released today, Nick Setyan from Wedbush maintained a Buy rating on Texas Roadhouse (TXRH – Research Report), with a price target ...
Tesla analysis: Wedbush sees shares doubling, HSBC warns of a 50% decline, SA analysts are mixed
HSBC lowered its price target on Tesla ( NASDAQ: TSLA) to $130 on the view that there are no quick fixes for the electric ...
IBM in spotlight as Wedbush adds to Best Ideas List
IBM (IBM) was in focus on Monday as Wedbush Securities added the IT giant to its Best Ideas List. Read for more.